U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.7024C>T (p.Gln2342Ter) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV005357340.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.7024C>T (p.Gln2342Ter)]

NM_000059.4(BRCA2):c.7024C>T (p.Gln2342Ter)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.7024C>T (p.Gln2342Ter)
HGVS:
  • NC_000013.11:g.32354877C>T
  • NG_012772.3:g.44398C>T
  • NM_000059.4:c.7024C>TMANE SELECT
  • NP_000050.2:p.Gln2342Ter
  • NP_000050.3:p.Gln2342Ter
  • LRG_293t1:c.7024C>T
  • LRG_293:g.44398C>T
  • LRG_293p1:p.Gln2342Ter
  • NC_000013.10:g.32929014C>T
  • NM_000059.3:c.7024C>T
  • U43746.1:n.7252C>T
  • p.Gln2342*
Nucleotide change:
7252C>T
Protein change:
Q2342*
Links:
dbSNP: rs80358928
Molecular consequence:
  • NM_000059.4:c.7024C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
BREAST CANCER, FAMILIAL; Hereditary breast cancer; hereditary breast carcinoma
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480
Name:
Breast-ovarian cancer, familial, susceptibility to, 2 (BROVCA2)
Synonyms:
BRCA2 Hereditary Breast and Ovarian Cancer
Identifiers:
MONDO: MONDO:0012933; MedGen: C2675520; Orphanet: 145; OMIM: 612555

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005915627Department of Pathology and Laboratory Medicine, Sinai Health System
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 14, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer.

Panchal S, Shachar O, O'Malley F, Crystal P, Escallon J, Crook J, Bane A, Bordeleau L.

Nat Rev Clin Oncol. 2009 Oct;6(10):604-7. doi: 10.1038/nrclinonc.2009.116.

PubMed [citation]
PMID:
19787003

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.

Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E.

BMC Cancer. 2017 Jun 21;17(1):438. doi: 10.1186/s12885-017-3422-2.

PubMed [citation]
PMID:
28637432
PMCID:
PMC5480128
See all PubMed Citations (4)

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System, SCV005915627.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 27, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search